Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and ...
Sanara MedTech (SMTI) just reported a shakeup in its business model by winding down its Tissue Health Plus division while also topping quarterly earnings estimates. Investors are watching to see how ...
Sanara MedTech Inc. (NASDAQ:SMTI) shareholders might be concerned after seeing the share price drop 10% in the last quarter. But that doesn't change the fact that the returns over the last three years ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Sanara MedTech is growing its top line at triple-digits on an annualized basis. The company is expanding into new territories and capturing additional contract wins along the way. Valuations are ...
Law Offices of Howard G. Smith announces an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company’s possible violations of federal ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.
Sanara MedTech ( NASDAQ:SMTI ) Full Year 2024 Results Key Financial Results Revenue: US$86.7m (up 33% from FY 2023... Sanara MedTech Inc (SMTI) reports a 33% increase in net revenue, driven by robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results